How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

907 results for

Acne Vulgaris Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Pharmaceutical or non-pharmaceutical treatment for acne vulgaris: a network meta-analysis

Pharmaceutical or non-pharmaceutical treatment for acne vulgaris: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites (...) meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis

2019 PROSPERO

62. Dietary interventions for treatment of acne vulgaris

Dietary interventions for treatment of acne vulgaris Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith (...) meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis

2019 PROSPERO

63. Serum levels of leptin and adiponectin in patients with acne vulgaris

Serum levels of leptin and adiponectin in patients with acne vulgaris Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2019 PROSPERO

64. A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study (...) of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03028363 Recruitment Status : Completed First Posted : January 23, 2017 Results First Posted : February 5, 2019 Last Update Posted : February 5, 2019 Sponsor: Dermira, Inc. Information provided

2017 Clinical Trials

65. A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03127956 Recruitment Status : Completed First Posted : April 25, 2017 Results First Posted : February 5, 2019 Last Update Posted : February 5, 2019 Sponsor

2017 Clinical Trials

66. Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03132194 Recruitment Status : Completed First Posted : April 27, 2017 Last Update Posted : May 4, 2017

2017 Clinical Trials

67. Vitamin A and Azithromycin for Acne Vulgaris

Vitamin A and Azithromycin for Acne Vulgaris Vitamin A and Azithromycin for Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Vitamin A and Azithromycin for Acne Vulgaris The safety (...) Party): DR. VINOD C TAWAR, Manchanda Medical Clinic Study Details Study Description Go to Brief Summary: Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups. Condition or disease Intervention/treatment Phase Acne Vulgaris Drug: Vitamin

2017 Clinical Trials

68. A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning (...) You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier

2017 Clinical Trials

69. Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.

Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2017 Clinical Trials

70. Cutaneous JAK in Vitiligo and Acne Vulgaris.

Cutaneous JAK in Vitiligo and Acne Vulgaris. Cutaneous JAK in Vitiligo and Acne Vulgaris. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Cutaneous JAK in Vitiligo and Acne Vulgaris. The safety (...) that many pro inflammatory interleukins use JAK/STAT components for signal transduction . Condition or disease Intervention/treatment Vitiligo and Acne Vulgaris Diagnostic Test: skin biopsy Detailed Description: The JAK/STAT signaling pathway transmits information from extracellular chemical signals to the nucleus resulting in DNA transcription. Binding of ligands, such as interferon and interleukins, to their specific transmembrane receptors activate associated JAKs. Phosphorylation of STAT follows

2017 Clinical Trials

71. Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris

Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03168334 Recruitment Status : Completed First

2017 Clinical Trials

72. A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris

A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Phase 3, Double (...) -Blind 2 Arm Study in the Treatment of Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03168321 Recruitment Status : Completed First Posted : May 30, 2017 Last Update Posted : March 15, 2019 Sponsor: Valeant Pharmaceuticals International, Inc. Information provided by (Responsible Party

2017 Clinical Trials

73. A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study (...) of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03073486 Recruitment Status : Completed First Posted : March 8, 2017 Results First Posted : February 5, 2019 Last Update Posted : February 5, 2019 Sponsor: Dermira, Inc. Information provided

2017 Clinical Trials

74. Silk textile with antimicrobial AEM5772/5 (Dermasilk): a pilot study with positive influence on acne vulgaris on the back. Full Text available with Trip Pro

Silk textile with antimicrobial AEM5772/5 (Dermasilk): a pilot study with positive influence on acne vulgaris on the back. The use of special silk textiles (Dermasilk) has shown positive effects on chronic inflammatory diseases like lichen sclerosus et atrophicus, atopic dermatitis, diabetic ulcerations, and vulvovaginal candidiasis.Wearing T-shirts of this particular fabric could be useful in the management of patients with acne vulgaris on the back and trunk.Dermasilk T-shirts were given (...) in lifestyle and living conditions.The use of Dermasilk textiles in other subacute-chronic inflammatory skin diseases has shown positive effects. This is the first report on their safe and effective use in the management of acne vulgaris papulopustulosa corporis.© 2017 The International Society of Dermatology.

2017 International Journal of Dermatology

75. Systematic review and meta-analysis of the association between acne vulgaris and depression and anxiety

Systematic review and meta-analysis of the association between acne vulgaris and depression and anxiety Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2018 PROSPERO

76. Medication Causes of Acne Vulgaris

Medication Causes of Acne Vulgaris Medication Causes of Acne Vulgaris Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Medication (...) Causes of Acne Vulgaris Medication Causes of Acne Vulgaris Aka: Medication Causes of Acne Vulgaris , Drug-induced Acne Vulgaris From Related Chapters II. Causes See Adrenocorticotropic Hormone (ACTH) ( ) Iodide s (e.g. ) s with s that have high (e.g. ) (e.g. ) (e.g. , Loestrin) III. References Fitzpatrick (2009) Color Atlas and Synopsis of Clinical Dermatology, 6th ed, McGraw-Hill, New York Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search

2018 FP Notebook

77. Acne Vulgaris

Acne Vulgaris Acne Vulgaris Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Acne Vulgaris Acne Vulgaris Aka: Acne Vulgaris , Acne From (...) Rapidly progressive, severe inflammatory acne Associated findings Bone diathesis Acne conglobata Severe Associated with dissecting scalp Associated with suppurativa Aggressive treatment required faciale Rapidly progressive facial (esp cheeks) May be a variant of Affects adult women VII. Differential Diagnosis See See secondary acne causes above Perioral Dermatitis VIII. Management See (includes ) IX. Resources: Patient Education Information from your Family Doctor: Acne in Teens X. References Habif

2018 FP Notebook

78. Acne Vulgaris Pathophysiology

Acne Vulgaris Pathophysiology Acne Vulgaris Pathophysiology Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Acne Vulgaris (...) Pathophysiology Acne Vulgaris Pathophysiology Aka: Acne Vulgaris Pathophysiology From Related Chapters II. Pathophysiology: Overview Progression (4 step process) Androgen Mediated Production Keratinous Obstruction of sebaceous follicle outlet (Results in formation of comedones) l Colonization of trapped sebum (with Propionibacterium acnes) Inflammatory reaction ( s, s and cysts) Images Lewis (1918) Gray's Anatomy 20th ed (in at or ) III. Pathophysiology: Androgen Mediated Sebum Production composition s esters

2018 FP Notebook

79. A systematic review and meta-analysis of blue light therapies for acne vulgaris

A systematic review and meta-analysis of blue light therapies for acne vulgaris Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2018 PROSPERO

80. The Management of Acne Vulgaris in Primary Care: A cohort study of consulting and prescribing patterns using CPRD. Full Text available with Trip Pro

The Management of Acne Vulgaris in Primary Care: A cohort study of consulting and prescribing patterns using CPRD. Effective management of acne vulgaris in primary care involves support (usually provided over a number of consultations) and prescription of effective treatments. However, consulting and prescribing patterns for acne in primary care are not well described.To describe the rate of primary-care consultations and follow-up consultations; prescribing patterns, including overall use (...) of acne-related medications (ARMs); and initial and follow-up prescription for acne vulgaris in the U.K.U.K. primary-care acne consultations and prescriptions for ARMs were identified in the Clinical Practice Research Datalink. Annual consultation rates (between 2004 and 2013) by age and sex, new consultations and consultations in the subsequent year were calculated, along with prescribing trends - during a new consultation and over the subsequent 90 days and year - using the number of registered

2016 British Journal of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>